Open AccessControversies in the Definition and Treatment of Idiopathic Short Stature (ISS)
Author(s) -
Stefania Pedicelli,
Emanuela Peschiaroli,
Enrica Violi,
Stefano Cianfarani
Publication year - 2011
Publication title -
jcrpe
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.566
H-Index - 35
eISSN - 1308-5735
pISSN - 1308-5727
DOI - 10.4008/jcrpe.v1i3.53
Subject(s) - medicine , idiopathic short stature , short stature , endocrine system , pediatrics , growth hormone , growth hormone deficiency , bone age , hormone
The term idiopathic short stature (ISS) refers to short children with no identifiable disorder of the growth hormone (GH)/insulin like growth factor (IGF) axis and no other endocrine, genetic or organ system disorder. This heterogeneous group of short children without GH deficiency (GHD) includes children with constitutional delay of growth and puberty, familial short stature, or both, as well as those with subtle cartilage and bone dysplasias. In rare cases, ISS is due to IGF molecular abnormalities. In this review we tackle the major challenges in the definition and treatment of ISS.